Mission statement

The European Malignant Hyperthermia (MH) Group was formed in 1983 with the following aims:

  • to provide a forum for discussion between the various European MH investigation centers
  • to improve, maintain and update the quality of diagnostic standards of MH susceptibility
  • to increase knowledge about MH for the medical community and for patients
  • to promote inter-laboratory scientific research on MH
  • to establish a common database
  • to promote research into the molecular aetiology and new pharmacologically-based treatments of MH